CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-07 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −59,066 | $29.36 | $1.7M | 18,867,521 |
| 2023-02-06 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −30,497 | $29.84 | $910K | 18,945,781 |
| 2023-02-06 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −14,752 | $30.09 | $444K | 18,931,029 |
| 2023-02-03 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −6,318 | $29.85 | $189K | 19,038,746 |
| 2023-02-03 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −62,468 | $30.46 | $1.9M | 18,976,278 |
| 2023-02-02 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −86,801 | $29.70 | $2.6M | 19,045,064 |
| 2023-02-01 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −26,661 | $28.78 | $767K | 19,167,038 |
| 2023-02-01 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −35,173 | $29.19 | $1.0M | 19,131,865 |
| 2023-01-31 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −3,316 | $28.88 | $96K | 19,264,266 |
| 2023-01-31 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −70,567 | $29.50 | $2.1M | 19,193,699 |
| 2023-01-30 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −67,026 | $29.32 | $2.0M | 19,279,486 |
| 2023-01-30 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −11,904 | $30.21 | $360K | 19,267,582 |
| 2023-01-24 | Pang Phillip Chief Medical Officer | Grant or award | +25,406 | $1.58 | $40K | 169,406 |
| 2023-01-24 | Pang Phillip Chief Medical Officer | Grant or award | +4,594 | $5.18 | $24K | 174,000 |
| 2023-01-24 | Pang Phillip Chief Medical Officer | Sale | −30,000 | $30.00 | $900K | 144,000 |
| 2023-01-24 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −25,406 | 13,576 | ||
| 2023-01-24 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,594 | 37,535 | ||
| 2023-01-23 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −6,400 | $27.80 | $178K | 19,376,624 |
| 2023-01-23 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −30,112 | $28.45 | $857K | 19,346,512 |
| 2023-01-20 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −21,585 | $26.86 | $580K | 19,505,797 |
Page 17 of 54 · 1,063 trades